# Beat2Bit Research Methodology

## 1. Introduction
This document describes the research methodology employed in the Beat2Bit project for ECG arrhythmia detection. The approach combines rigorous experimental design, statistical validation, and reproducible research practices to ensure scientific validity and clinical relevance.

## 2. Research Paradigm

### 2.1. Empirical-Experimental Approach
The Beat2Bit project follows an empirical-experimental research paradigm where:
- Hypotheses are derived from literature review and theoretical considerations
- Experiments are designed to test these hypotheses under controlled conditions
- Results are analyzed using appropriate statistical methods
- Conclusions are drawn based on empirical evidence

### 2.2. Iterative Refinement
Research proceeds through iterative cycles:
1. **Exploration**: Initial investigation of problem space and existing solutions
2. **Hypothesis Formation**: Development of testable predictions
3. **Experimentation**: Controlled testing of hypotheses
4. **Analysis**: Statistical evaluation of results
5. **Refinement**: Iteration based on findings

## 3. Research Questions and Hypotheses

### 3.1. Primary Research Question
*How much can an ECG arrhythmia detection neural network be compressed and optimized for edge deployment while maintaining acceptable classification performance?*

### 3.2. Specific Hypotheses

#### H1: Model Compression Hypothesis
*Applying magnitude pruning followed by INT8 quantization will reduce model size by at least 6x while maintaining classification performance within 5% of the baseline FP32 model.*

#### H2: Architecture Optimization Hypothesis
*Alternative 1D CNN architectures (varying filter sizes, layer depths, and connectivity patterns) can achieve better accuracy-size trade-offs than the baseline architecture.*

#### H3: Optimization Order Hypothesis
*The sequence of applying pruning before quantization yields better performance than quantization before pruning or simultaneous application.*

#### H4: Generalizability Hypothesis
*Models trained and optimized on the MIT-BIH dataset will demonstrate reasonable performance on other openly available ECG arrhythmia datasets.*

## 4. Experimental Design

### 4.1. Comparative Experimental Design
The primary experimental approach uses controlled comparisons:
- **Within-Subjects Design**: Same dataset, same random seeds, different model variants
- **Between-Subjects Design**: Different datasets, same model architecture
- **Factorial Design**: Combination of optimization techniques (pruning × quantization × architecture)

### 4.2. Variables Classification

#### Independent Variables (Manipulated)
- Model architecture parameters (filter sizes, number of layers, etc.)
- Pruning parameters (sparsity level, schedule, fine-tuning epochs)
- Quantization parameters (precision, calibration method)
- Training hyperparameters (learning rate, batch size, epochs)
- Preprocessing parameters (window size, normalization method)

#### Dependent Variables (Measured)
- Classification performance (accuracy, sensitivity, specificity, F1-score)
- Model complexity (parameter count, model size, FLOPs)
- Inference characteristics (latency, throughput)
- Optimization effectiveness (compression ratio, performance retention)

#### Control Variables (Held Constant)
- Dataset version and source
- Random seeds for reproducibility
- Evaluation methodology
- Statistical significance threshold (α = 0.05)
- Baseline model for comparison

### 4.3. Experimental Conditions
Each experiment defines specific conditions:
- **Baseline Condition**: FP32 model with standard architecture and training
- **Single Optimization Conditions**: Pruning-only, Quantization-only
- **Combined Optimization Conditions**: Pruning + Quantization in various orders
- **Architecture Variants**: Different CNN configurations
- **Dataset Variants**: Different openly available ECG datasets (when applicable)

## 5. Data Collection Procedures

### 5.1. Dataset Acquisition and Validation
1. **Source Verification**: Confirm dataset availability from official sources (PhysioNet)
2. **Version Documentation**: Record exact dataset versions and download dates
3. **Integrity Checking**: Verify checksums/hashes where available
4. **License Compliance**: Ensure usage complies with data use agreements
5. **Preprocessing Standardization**: Apply identical preprocessing to all datasets

### 5.2. Experimental Replication
1. **Independent Runs**: Multiple complete experimental runs with different random seeds
2. **Cross-Validation**: Patient-independent cross-validation where applicable
3. **Blind Analysis**: Where feasible, analysts blinded to condition assignments
4. **Randomization**: Random assignment of experimental units to conditions

### 5.3. Measurement Protocol
1. **Calibration**: Verify measurement tools and procedures
2. **Baseline Recording**: Record baseline measurements before interventions
3. **Standardized Timing**: Conduct measurements at standardized times
4. **Environmental Control**: Control for known confounding factors
5. **Duplicate Measurements**: Where appropriate, take duplicate measurements

## 6. Analysis Procedures

### 6.1. Descriptive Analysis
1. **Data Cleaning**: Identify and handle outliers, missing values, and anomalies
2. **Summary Statistics**: Calculate means, medians, standard deviations, ranges
3. **Data Visualization**: Create appropriate plots for data exploration
4. **Distribution Assessment**: Examine normality and distribution shapes

### 6.2. Inferential Analysis
1. **Assumption Testing**: Verify assumptions for statistical tests
2. **Hypothesis Testing**: Apply appropriate parametric or non-parametric tests
3. **Effect Size Calculation**: Compute standardized effect sizes
4. **Confidence Intervals**: Establish uncertainty intervals for estimates
5. **Power Analysis**: Conduct post-hoc power calculations when relevant

### 6.3. Comparative Analysis
1. **Baseline Comparison**: Compare all experimental conditions to baseline
2. **Pairwise Comparisons**: Test differences between specific conditions
3. **Multiple Testing Correction**: Apply adjustments for multiple comparisons
4. **Trend Analysis**: Test for dose-response or monotonic relationships
5. **Interaction Effects**: Examine whether effects depend on other factors

### 6.4. Model-Specific Analyses
1. **Ablation Studies**: Determine contribution of individual components
2. **Sensitivity Analysis**: Examine robustness to parameter variations
3. **Subgroup Analysis**: Analyze performance across different beat types
4. **Error Analysis**: Characterize types and patterns of misclassification
5. **Threshold Optimization**: Determine optimal operating points

## 7. Validation Strategies

### 7.1. Internal Validation
- **Cross-Validation**: Patient-independent k-fold cross-validation
- **Bootstrap Resampling**: Estimate sampling variability
- **Split-Sample Validation**: Hold-out validation sets
- **Time-Series Validation**: For temporal data considerations

### 7.2. External Validation
- **Cross-Dataset Validation**: Train on one dataset, test on another
- **Literature Comparison**: Compare results to established benchmarks
- **Clinical Relevance Assessment**: Evaluate practical significance
- **Robustness Testing**: Assess performance under noise and artifacts

### 7.3. Reliability Assessment
- **Test-Retest Reliability**: Consistency across repeated measurements
- **Inter-Rater Reliability**: Agreement between different implementations
- **Internal Consistency**: Cohesiveness of related measurements
- **Equivalence Testing**: Demonstrate similarity to reference standards

## 8. Bias Mitigation Strategies

### 8.1. Selection Bias
- **Random Sampling**: Use random sampling where applicable
- **Complete Enumeration**: Analyze all available data when possible
- **Propensity Score Matching**: For observational comparisons
- **Sensitivity Analysis**: Assess impact of potential selection bias

### 8.2. Measurement Bias
- **Blinding**: Blind outcome assessment when feasible
- **Standardized Instruments**: Use validated measurement procedures
- **Calibration**: Regular calibration of measurement tools
- **Objective Metrics**: Prefer objective over subjective measures

### 8.3. Confounding Bias
- **Random Assignment**: Randomly assign experimental units to conditions
- **Matching**: Match on potential confounders
- **Statistical Control**: Include confounders in statistical models
- **Stratification**: Analyze within homogeneous subgroups

### 8.4. Publication Bias Mitigation
- **Preregistration**: Consider preregistering hypotheses and methods
- **Full Disclosure**: Report all experimental conditions and outcomes
- **Negative Results**: Publish null and negative findings when informative
- **Open Science Practices**: Share data, code, and materials

## 9. Reproducibility Practices

### 9.1. Computational Reproducibility
- **Code Availability**: Share all analysis code with appropriate documentation
- **Environment Capture**: Record exact computational environments
- **Random Seed Control**: Set and report all random seeds
- **Version Control**: Use Git for code versioning with detailed commit messages
- **Automated Pipelines**: Create reproducible analysis pipelines

### 9.2. Methodological Reproducibility
- **Detailed Protocols**: Provide step-by-step experimental procedures
- **Precise Definitions**: Operationally define all variables and procedures
- **Reference Materials**: Cite or include references to standardized methods
- **Qualitative Descriptions**: Supplement quantitative methods with qualitative context

### 9.3. Results Reproducibility
- **Data Sharing**: Share de-identified data where permissible and ethical
- **Analysis Scripts**: Provide scripts that reproduce all reported analyses
- **Interactive Notebooks**: Use Jupyter notebooks for exploratory work
- **Containerization**: Consider Docker or similar for environment capture

### 9.4. Inferential Reproducibility
- **Statistical Detail**: Report sufficient statistics to recompute tests
- **Raw Data Access**: Enable access to raw data for reanalysis
- **Decision Rules**: Explicitly state criteria for statistical significance
- **Multiple Testing Transparency**: Disclose all tests conducted

## 10. Ethical Considerations

### 10.1. Data Ethics
- **Privacy Protection**: Ensure no identifiable health information is used
- **Data Governance**: Follow data use agreements and institutional policies
- **Secondary Use**: Respect limitations on secondary data use
- **Beneficence**: Aim to produce knowledge that benefits patients and society

### 10.2. Research Ethics
- **Honesty**: Report methods, results, and interpretations truthfully
- **Objectivity**: Minimize bias in design, execution, and interpretation
- **Integrity**: Adhere to scholarly and scientific standards
- **Carefulness**: Avoid careless errors and negligence

### 10.3. Social Responsibility
- **Public Communication**: Communicate findings accurately to public audiences
- **Mentoring**: Support training and development of junior researchers
- **Collegiality**: Share resources and collaborate openly
- **Service**: Contribute to peer review and academic service

## 11. Quality Assurance

### 11.1. Internal Quality Controls
- **Positive and Negative Controls**: Include where applicable
- **Blind Duplicates**: Where feasible, include blinded duplicate samples
- **Reference Materials**: Use certified reference materials when available
- **Instrument Qualification**: Verify suitability of measurement tools

### 11.2. External Quality Assessment
- **Proficiency Testing**: Participate in external quality assessment schemes
- **Interlaboratory Comparison**: Compare results with other laboratories
- **Certification**: Maintain appropriate certifications and accreditations
- **Audit Readiness**: Prepare for internal and external audits

### 11.3. Continuous Improvement
- **Feedback Loops**: Incorporate lessons learned into future work
- **Method Updates**: Update methods based on technological advances
- **Training**: Ensure personnel are adequately trained
- **Documentation Maintenance**: Keep documentation current and accurate

## 12. Limitations and Assumptions

### 12.1. Methodological Limitations
- **Algorithm-Centric Focus**: Primary focus on algorithmic rather than system-level improvements
- **Simulation Constraints**: Latency measurements simulated rather than measured on actual hardware
- **Dataset Limitations**: Reliance on publicly available datasets which may have biases
- **Binary Classification**: Focus on normal vs. abnormal rather than multi-class arrhythmia typing

### 12.2. Assumptions
- **Stationarity**: Assume statistical properties remain stable over short periods
- **Representativeness**: Assume MIT-BIH is representative of target population
- **Generalizability**: Assume findings extend to similar populations and settings
- **Technical Feasibility**: Assume optimized models can be deployed on target hardware

### 12.3. Delimitations
- **Scope Limitation**: Focus on 1D CNN architectures for ECG arrhythmia detection
- **Exclusion Criteria**: Exclude invasive or clinically impractical approaches
- **Time Constraints**: Limit to feasible experimental timelines
- **Resource Constraints**: Work within available computational and human resources

## 13. References
1. Portney, L. G., & Watkins, M. P. (2015). Foundations of clinical research: Applications to evidence-based practice (4th ed.).
2. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.).
3. Wasserstein, R. L., & Lazar, N. A. (2016). The ASA's statement on p-values: Context, process, and purpose. The American Statistician, 70(2), 129-133.
4. Ioannidis, J. P. A. (2005). Why most published research findings are false. PLoS Medicine, 2(8), e124.
5. Nosek, B. A., et al. (2015). The reproducibility crisis: Causes, consequences, and responses. Science, 348(6242), 1422-1425.
6. Collins, F. S., & Tabak, L. A. (2014). Policy: NIH plans to enhance reproducibility. Nature, 505(7484), 612-613.

---
*Methodology Version: 1.0.0*
*Last Updated: $(date)*
*Compatible with Beat2Bit Experimental Protocol v1.0.0*